Shah metacorp Limited announced its unaudited consolidated and standalone financial results for the quarter and nine months ended December 31, 2025. The Board of Directors approved these results at their meeting held on February 12, 2026, following review by the Audit Committee.

Consolidated Financial Performance

The company's consolidated operations showed mixed results for the quarter ended December 31, 2025. Revenue from operations declined to ₹5,003.97 lakhs compared to ₹6,677.25 lakhs in the previous quarter and ₹3,985.86 lakhs in the corresponding quarter of the previous year.

For the nine-month period ended December 31, 2025, consolidated revenue from operations reached ₹14,571.17 lakhs compared to ₹13,468.22 lakhs in the corresponding period of the previous year, representing an increase of 8.19%. Net profit for the nine-month period stood at ₹400.33 lakhs.

Standalone Performance

On a standalone basis, Shah Metacorp reported revenue from operations of ₹4,580.87 lakhs for Q3FY26, compared to ₹3,589.33 lakhs in the corresponding quarter of the previous year. Net profit for the quarter was ₹57.45 lakhs versus ₹274.11 lakhs in Q3FY25.

Corporate Developments

Several significant corporate actions were highlighted in the results:

Capital Structure Changes:

• The company increased its authorized share capital from ₹110 crores to ₹130 crores during the current quarter
• Paid-up equity share capital stands at ₹8,852.11 lakhs with face value of ₹1 per share

Rights Issue Initiative:

• Shah Metacorp has initiated the process for a rights issue aggregating up to ₹50.00 crore, approved by the Board of Directors on December 29, 2025
• The Draft Letter of Offer has been filed with BSE Limited and National Stock Exchange of India Limited

Acquisitions and Investments:

• The company acquired 85.60% stake in General Capital and Holding Company Private Limited and 80.00% stake in Metacorp Trading LLC through share swap arrangements
• Board approved investment of up to USD 1 lakh in Shah Metacorp Holding USA INC through equity share subscription

Key Concerns and Provisions

The auditor's review report highlighted trade receivables amounting to ₹88.82 crores that have remained long outstanding and unrecovered as of December 31, 2025. The company has recognized a provision for doubtful debts of ₹68.81 crores against this balance. Management expects recovery in subsequent quarters, with unrecovered portions to be written off by March 31, 2026 if necessary.

Business Operations

Shah Metacorp's principal business involves manufacturing and sale of stainless steel products. The consolidated results include financial performance of subsidiary companies Shah Agrocorp Private Limited, General Capital and Holding Company Private Limited, Metacorp Trading LLC, and Western Urja Private Limited, along with associate company Goldman Hotels & Resorts Private Limited.

Shah Metacorp Limited has received trading approval from the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) for 25.58 crore equity shares, marking a significant corporate action for the company. This latest development involves a preferential allotment to both promoters and non-promoters at a price of Rs. 4.71 per share.

Latest Share Issuance Details

Official Trading Approvals

The company received official trading approval letters from both stock exchanges on December 29, 2025. BSE issued approval letter LOD/PREF/SV/483/2025-2026, while NSE provided approval under reference NSE/LIST/52366. Both exchanges confirmed that the shares are listed and admitted to dealings from December 30, 2025. The approvals were signed by designated officials including Kinnar Mehta and Pranav Rewale from BSE, and Jalpa Mehta from NSE.

Lock-in Period Details

The preferential allotment comes with specific lock-in arrangements for different tranches of shares:

Regulatory Compliance and Documentation

In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shah Metacorp Limited has formally notified the stock exchanges about this development. The company submitted all required documentation to regulatory authorities, with Director Mona Viral Shah (DIN: 02343194) signing the official intimation letter on December 30, 2025.

Market Impact and Implications

This substantial preferential allotment of 25.58 crore shares represents a significant expansion in the company's equity base. The inclusion of both promoters and non-promoters in this allotment indicates a broader capital raising strategy. The issue price of Rs. 4.71 with a premium of Rs. 3.71 per share demonstrates the company's ability to raise funds at attractive valuations. Market participants will be closely monitoring the impact of this large equity infusion on the company's shareholding pattern and stock performance.